TGFB2 and metabolic dysfunction-associated steatotic liver disease: In another study of NAFLD individuals, the ratio of serum expression of TGFB2 to its associated lncRNAs, TGFB2-OT1, was included in a panel together with FIB-4 markers, and this panel was able to identify fibrosis with high accuracy (AUROC: 0.891) [198].